Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment
Clinical trial NCT06031259 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06031259
- Sponsor
- Takeda
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-05
- Primary completion
- 2029-01-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.